Invention Grant
US07829091B2 Therapy targeting FLT4 (VEGER-3) expressed in blood vessels
有权
靶向FLT4（VEGER-3）的治疗在血管中表达
- Patent Title: Therapy targeting FLT4 (VEGER-3) expressed in blood vessels
- Patent Title (中): 靶向FLT4（VEGER-3）的治疗在血管中表达
-
Application No.: US10774802Application Date: 2004-02-09
-
Publication No.: US07829091B2Publication Date: 2010-11-09
- Inventor: Kari Alitalo
- Applicant: Kari Alitalo
- Applicant Address: AU Toorak, Victoria
- Assignee: Vegenics Limited
- Current Assignee: Vegenics Limited
- Current Assignee Address: AU Toorak, Victoria
- Agency: Marshall, Gerstein & Borun LLP
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention provide purified Flt4 receptor tyrosine kinase polypeptides and fragments thereof, polynucleotides encoding such polypeptides, antibodies that specifically bind such polypeptides, and uses therefor.
Public/Granted literature
- US20040208879A1 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy Public/Granted day:2004-10-21
Information query
